Skip to contentR
Rigel Pharmaceuticals Inc
R
RIGLRigel Pharmaceuticals Inc Released May 7, 2014, during market hours
10-Q filed May 7, 2014, 37 days after period end · 0001104659-14-035662
Q1 2014 · 10-Q
Revenue—
Net income—
EPS Diluted-$0.25-$0.25N/M vs Q1 2013 No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
N/M vs Q4 2013
Operating Income-$22,385,000N/M Operating Cash Flow-$16,428,000N/M Free Cash Flowderived-$16,606,000N/M ended Mar 31, 2014 · filed May 7, 2014 · 37 d after period end
8.9% from the close of May 6, 2014 to the close of May 7, 2014, the first after the release.
during market hours$3.02$2.75 Apr 9May 7Jun 2